Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03058835
PHASE4

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

The overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP procurement through the established access procedures, and adherence to Truvada PrEP among US women at risk for HIV acquisition.

Key Details

Gender

FEMALE

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

162

Start Date

2016-09

Completion Date

2024-09

Last Updated

2026-08-13

Healthy Volunteers

Yes

Interventions

DRUG

tenofovir disoproxil and emtricitabine

Pre-exposure Prophylaxis with Truvada will be distributed to all participants eligible to receive PrEP.

Locations (4)

Emory University

Atlanta, Georgia, United States

Rush University Medical Center

Chicago, Illinois, United States

New Jersey Medical School Clinical Research Center

Newark, New Jersey, United States

West Virginia University

Morgantown, West Virginia, United States